Evidence map›Paper›PMID 40674500›Full record

ArticleScience (New York, N.Y.)2025

Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders.

Jason Yang, Yunhan Xu, David R Ziehr, Martin S Taylor, Max L Valenstein, Evgeni M Frenkel, Jack R Bush, Kate Rutter, Igor Stevanovski, Charlie Y Shi and 6 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The regulation, function and disease relevance of cytoplasmic tRNAs.Nature reviews. Molecular cell biology · 2026
    Review
  6. Enzymology of the metazoan tRNA ligase complex: a lifetime in cycles.Cellular and molecular life sciences : CMLS · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jason YangCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0009-0007-9977-0433
Yunhan XuCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
David R ZiehrCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-8029-7259
Martin S TaylorDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.ORCID 0000-0001-5824-142X
Max L ValensteinCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7616-0148
Evgeni M FrenkelInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
Jack R BushCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Kate RutterCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0009-0006-8558-0818
Igor StevanovskiGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-7713-1979
Charlie Y ShiWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0001-5229-9196
Maheswaran KesavanCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0009-0006-2141-5047
Ricardo Mouro PintoCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-6744-2805
Ira DevesonGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0003-3861-0472
David P BartelWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-3872-2856
David M SabatiniInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-1446-7256
Raghu R ChivukulaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-5264-3196

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Teresa Gomez-Isla · 2019 to 2026
$36.5M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Post-transcriptional gene regulationR35GM118135 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI DAVID P BARTEL · 2016 to 2026
$10.7M
P&F programP30DK135043 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Dennis Brown · 2023 to 2026
$5.4M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Somatic Repeat Expansions as a Therapeutic Target for Trinucleotide Repeat DisordersR01NS126420 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Ricardo Mouro Pinto · 2022 to 2026
$2.0M
Elucidating structural, mechanistic, and allosteric determinants of mTOR Complex 2 (mTORC2) signaling.K08DK129824 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TAYLOR, MARTIN S · 2021 to 2025
$853k
HD Upgrade to a Nikon A1R Confocal Imaging PlatformS10OD032211 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2022 to 2022
$296k
NIA NIH HHS P30 AG062421NIDDK NIH HHS K08 DK129824NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK135043NIGMS NIH HHS R35 GM118135NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM087237NIH HHS S10 OD032211NINDS NIH HHS R01 NS126420
6 · The paper itself

Abstract

Aggregation-prone polyglycine-containing proteins produced from expanded GGC repeats are implicated in an emerging family of neurodegenerative disorders. In this study, we showed that polyglycine itself forms aggregates that incorporate endogenous glycine-rich proteins, including FAM98B, a component of the transfer RNA (tRNA) ligase complex (tRNA-LC) that harbors the most glycine-rich sequence in the human proteome. Through this glycine-rich intrinsically disordered region (IDR), polyglycine sequesters and depletes the tRNA-LC, disrupting tRNA processing. Accordingly, patient tissues revealed aggregate-associated FAM98B depletion and accumulation of aberrant tRNA splicing intermediates. Furthermore, Fam98b depletion in adult mice caused progressive motor coordination deficits and hindbrain pathology. Our data suggest that the FAM98B glycine-rich IDR mechanistically links previously disparate neurodegenerative disorders of protein aggregation and tRNA processing.

Indexed as

Carrier ProteinsIntrinsically Disordered ProteinsNeurodegenerative DiseasesPeptidesProtein Aggregation, PathologicalRNA Processing, Post-TranscriptionalRNA, TransferTrinucleotide Repeat ExpansionAnimalsHumansMiceProtein AggregatesCarrier ProteinsFAM98B protein, humanIntrinsically Disordered ProteinsPeptidespolyglycineProtein AggregatesRNA, Transfer

Identifiers

PMID40674500
PMCPMC12603922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.